|
"hsu chih hung"的相關文件
顯示項目 111-120 / 175 (共18頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2009 |
Association of Clinical and Dosimetric Factors with Postoperative Pulmonary Complications in Esophageal Cancer Patients Receiving Intensity- Modulated Radiation Therapy and Concurrent Chemotherapy Followed by Thoracic Esophagectomy
|
許峰銘; 李元麒; 李章銘; 徐志宏; 林家齊; 蔡育傑; 吳簡坤; 成佳憲; HSU, FENG-MING; LEE, YUNG-CHIE; LEE, JANG-MING; HSU, CHIH-HUNG; LIN, CHIA-CHI; TSAI, YU-CHIEH; WU, JIAN-KUEN; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2009 |
Disseminated Peritoneal Leiomyomatosis Responds to Systemic Chemotherapy
|
林育靖; 魏凌鴻; 孫家棟; 鄭安理; 徐志宏; LIN, YU-CHIN; WEI, LIN-HUNG; SHUN, CHIA-TUNG; CHENG, ANN-LII; HSU, CHIH-HUNG |
| 國立臺灣大學 |
2009 |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
林家齊; 徐志宏; 成佳憲; 黃昭淵; 蔡育傑; 許峰銘; 黃國皓; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; CHENG, JASON CHIA- HSIEN; HUANG, CHAO-YUAN; TSAI, YU-CHIEH; HSU, FENG -MING; HUANG, KUO-HOW; CHENG, ANN-LII; PU, YEONG- SHIAU |
| 國立臺灣大學 |
2009 |
Prognostic Factors of Survival in 236 Advanced Hepatocellular Carcinoma Patients Enrolled in Prospective Clinical Trials of Systemic Therapy
|
林宗哲; 邵幼雲; 徐志宏; 許駿; 洪瑞隆; 鄭安理; LIN, ZONG-ZHE; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; HONG, RUEY-LONG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer
|
葉坤輝; 徐志宏; 許駿; 林璟宏; 沈盈君; 邱宗傑; 趙毅; 鄭安理; YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII |
| 國立臺灣大學 |
2008-07 |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu, Feng-Ming; Lin, Chia-Chi; Lee, Jang-Ming; Chang, Yih-Leong; Hsu, Chih-Hung; Tsai, Yu-Chieh; Lee, Yung-Chie; Cheng, Jason Chia-Hsien |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 國立臺灣大學 |
2008-04 |
Systemic therapy for metastatic urothelial carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Pu, Yeong-Shiau; Vogelzang, Nicholas J. |
顯示項目 111-120 / 175 (共18頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目
|
